Helsinki, November 14, 2014  Nasdaq (Nasdaq: NDAQ) announced that trading in Nexstim Plc shares commenced today on First North both in Helsinki (NXTMH) and in Stockholm (NXTMS). The company belongs to the Health Care sector, and is the 40th company to be admitted to trading on First North Nordic markets (Stockholm, Helsinki, Copenhagen and Iceland) in 2014. This is the first time a company is dual-listed simultaneously on two Nasdaq marketplaces.

Nexstim, formed in 2000 and based in Finland, is a medical technology company aiming to improve rehabilitation for stroke patients. Nexstim has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) device for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the company has developed a device for stroke therapy called Navigated Brain Therapy (NBT®). For more information please visit 

Janne Huhtala, CEO of Nexstim Oyj tolls the bell.

Lauri Rosendahl, President of Nasdaq Helsinki welcomes Nexstim CEO Janne Huhtala to the exchange.